Xeris Biopharma Holdings Inc (XERS)
Operating Expenses
$242.95M
TTM · Period ending: · USD
XERS Operating Expenses
Latest reported$242.95Mperiod ending
Latest reported$242.95Mperiod ending
XERS TTM Operating Expenses ($28.18M → $242.95M)
TTM operating expenses
High-resolution chart · PNG
XERS operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 242,950,000 | |
| 220,983,000 | |
| 213,537,000 | |
| 212,524,000 | |
| 209,439,000 | |
| 202,743,000 | |
| 197,174,000 | |
| 192,182,000 | |
| 183,646,000 | |
| 184,326,000 | |
| 176,568,000 | |
| 174,641,000 | |
| 172,854,000 | |
| 165,834,000 | |
| 169,554,000 | |
| 192,582,000 | |
| 181,510,000 | |
| 173,408,000 | |
| 151,643,000 | |
| 109,700,000 | |
| 97,887,000 | |
| 89,510,000 | |
| 94,653,000 | |
| 104,607,000 | |
| 114,642,000 | |
| 126,066,000 | |
| 123,499,000 | |
| 111,552,000 | |
| 96,682,000 | |
| 75,501,000 | |
| 61,767,000 | |
| 50,328,000 | |
| 42,545,000 | |
| 35,129,000 | |
| 28,181,000 |